Alterations in Resting-State Regional Cerebral Blood Flow Demonstrate Ongoing Pain in Osteoarthritis: An Arterial Spin-Labeled Magnetic Resonance Imaging StudyHOWARD, Matthew A; SANDERS, Duncan; CHOY, Ernest et al.Arthritis and rheumatism. 2012, Vol 64, Num 12, pp 3936-3946, issn 0004-3591, 11 p.Article

An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the kneeHUGGINS, John P; SMART, Trevor S; LANGMAN, Stephen et al.Pain (Amsterdam). 2012, Vol 153, Num 9, pp 1837-1846, issn 0304-3959, 10 p.Article

A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcersFRAY, M. Jonathan; DICKINSON, Roger P; HUGGINS, John P et al.Journal of medicinal chemistry (Print). 2003, Vol 46, Num 16, pp 3514-3525, issn 0022-2623, 12 p.Article

Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjectsGAI LING LI; WINTER, Helen; ARENDS, Rosalin et al.British journal of clinical pharmacology. 2012, Vol 73, Num 5, pp 706-716, issn 0306-5251, 11 p.Article

Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidinesFISH, Paul V; BARBER, Christopher G; O'GARA, Margaret et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 10, pp 2341-2351, issn 0022-2623, 11 p.Article